HI
REGN icon

Human Investing’s Regeneron Pharmaceuticals REGN Stock Holding History

Human Investing’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-86
Closed -$61.3K – 219
2024
Q4 		$61.3K Buy
+86
New +$72.2K 0.01% 135
2021
Q2 		– Sell
-147
Closed -$70K – 248
2021
Q1 		$70K Buy
147
+3
+2% +$1.46K 0.02% 145
2020
Q4 		$70K Sell
144
-5
-3% -$2.7K 0.02% 155
2020
Q3 		$83K Buy
149
+84
+129% +$50.9K 0.03% 135
2020
Q2 		$41K Sell
65
-52
-44% -$29.5K 0.01% 159
2020
Q1 		$57K Buy
117
+63
+117% +$26K 0.02% 147
2019
Q4 		$20K Buy
+54
New +$18.2K 0.01% 250

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Human Investing's REGN Position: Q1 2025 in Review

Human Investing sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 86 shares — an estimated $61.3K sold.

Human Investing first reported a position in REGN in Q4 2019 and held it in 7 quarters. The position peaked at $83K in Q3 2020. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Human Investing reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Human Investing sold 86 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $61.3K.
  • Human Investing first reported a position in Regeneron Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Human Investing's Regeneron Pharmaceuticals position peaked at $83K in Q3 2020.
  • 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Human Investing's 13F filing for Q1 2025, filed 15 May 2025.